NYSE$TFX
Teleflex Inc · Q3 2020 earnings
Q3 2020 earnings · · Investor relations
Briefing
Teleflex's financial performance reflected improving trends across many global product categories, particularly Interventional Urology and Vascular Access, with strength in the Americas.
Teleflex reported a 3.1% decrease in third quarter revenue to $628.3 million compared to the prior year. GAAP EPS decreased by 49.3% to $2.46, while adjusted diluted EPS decreased by 6.7% to $2.77. The company noted a negative impact of approximately $78 million due to COVID-19.
- Third quarter revenues were $628.3 million, a 3.1% decrease year-over-year, or 4.1% on a constant currency basis.
- GAAP diluted EPS from continuing operations was $2.46, compared to $4.85 in the prior year period.
- Adjusted diluted EPS from continuing operations was $2.77, a 6.7% decrease year-over-year.
- The company estimates COVID-19 had a net negative impact to revenue of approximately $78 million, or 12%.
Headline financials
Revenue & EPS history
Teleflex · Revenue · Quarterly
$628M
Revenue by segment
Teleflex · $375M total across 1 segment · Q3 2020
- Americas Segment$375M+0.1%100.0%
Forward guidance
Teleflex anticipates continued sequential improvement during the fourth quarter of 2020 compared to the third quarter results. The acquisition of Z-Medica is expected to be accretive to adjusted earnings per share in 2021.
Tailwinds
- Continued sequential improvement expected during the fourth quarter of 2020 compared to the third quarter results.
- Acquisition of Z-Medica is expected to be accretive to adjusted earnings per share in 2021.
- Revenue growth
- Gross margin profile
- Operating margin profile
Headwinds
- Adverse economic conditions associated with the COVID-19 global health pandemic
- Financial crisis
- Stay-at-home and other orders, which may significantly reduce customer spending
- Changes in business relationships with and purchases by or from major customers or suppliers
- Delays or cancellations in shipments
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2020
-0.4%
Avg return
Earnings day
-2.6%
Avg return
5 days after
-1.9%
Avg return
30 days after
53%
36 / 68 earnings
Positive
+12.5%
Q3 2023
Best reaction
-21.7%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +6.9% | +4.6% | +5.2% | |
| Q4 2025 | +6.5% | +9.2% | +3.9% | |
| Q3 2025 | -13.3% | -10.0% | -3.4% | |
| Q1 2025 | -8.2% | -12.0% | -10.8% | |
| Q4 2024 | -21.7% | -26.4% | -22.4% | |
| Q3 2024 | -10.2% | -13.5% | -18.0% | |
| Q2 2024 | +7.3% | +4.5% | +11.0% | |
| Q1 2024 | -4.0% | -4.7% | -1.2% | |
| Q4 2023 | -5.3% | -9.9% | -12.0% | |
| Q3 2023 | +12.5% | +9.2% | +21.4% | |
| Q2 2023 | -4.3% | -7.6% | -14.1% | |
| Q1 2023 | -5.2% | -7.4% | -13.1% | |
| Q4 2022 | -2.3% | -1.0% | +3.4% | |
| Q3 2022 | +3.1% | +5.6% | +8.6% | |
| Q2 2022 | -9.8% | -5.9% | -15.9% | |
| Q1 2022 | -9.7% | -9.9% | -8.3% | |
| Q4 2021 | +6.4% | +3.4% | +5.3% | |
| Q3 2021 | -2.5% | +0.9% | -16.7% | |
| Q2 2021 | -0.5% | -3.6% | -2.8% | |
| Q1 2021 | -4.8% | -7.0% | -9.4% | |
| Q4 2020 | -0.6% | +0.8% | +3.2% | |
| Q3 2020 | -5.0% | -0.8% | +10.8% | |
| Q2 2020 | -7.0% | -8.2% | -4.0% | |
| Q1 2020 | -6.7% | -3.5% | +2.8% | |
| Q4 2019 | -6.3% | -11.9% | -38.3% | |
| Q3 2019 | +4.9% | +1.9% | +7.1% | |
| Q2 2019 | +6.4% | +6.8% | +7.1% | |
| Q1 2019 | +7.0% | +4.9% | +2.7% | |
| Q4 2018 | -0.4% | +0.7% | +5.3% | |
| Q3 2018 | +6.4% | +6.9% | +14.4% | |
| Q2 2018 | -9.2% | -12.4% | -8.6% | |
| Q1 2018 | +0.6% | -0.7% | -0.2% | |
| Q4 2017 | -5.5% | -6.0% | -6.3% | |
| Q3 2017 | +6.1% | +7.7% | +9.9% | |
| Q2 2017 | +5.5% | +4.9% | +3.7% | |
| Q1 2017 | -4.4% | -7.2% | -1.2% | |
| Q4 2016 | +3.1% | +3.9% | +5.9% | |
| Q3 2016 | -9.7% | -11.2% | -2.7% | |
| Q2 2016 | +3.2% | +3.0% | +4.4% | |
| Q1 2016 | -2.8% | — | — | |
| Q4 2015 | +9.6% | — | — | |
| Q3 2015 | +2.4% | — | — | |
| Q2 2015 | -4.5% | — | — | |
| Q1 2015 | +0.6% | — | — | |
| Q4 2014 | +4.6% | — | — | |
| Q3 2014 | +0.7% | — | — | |
| Q2 2014 | +1.9% | — | — | |
| Q1 2014 | +1.6% | — | — | |
| Q4 2013 | +3.0% | — | — | |
| Q3 2013 | +5.5% | — | — | |
| Q2 2013 | +0.2% | — | — | |
| Q1 2013 | -5.9% | — | — | |
| Q4 2010 | -0.4% | — | — | |
| Q4 2012 | +1.0% | — | — | |
| Q3 2012 | +3.7% | — | — | |
| Q2 2012 | +4.4% | — | — | |
| Q1 2012 | +0.9% | — | — | |
| Q4 2011 | +0.9% | — | — | |
| Q3 2011 | -1.2% | — | — | |
| Q2 2011 | +0.9% | — | — | |
| Q1 2010 | +2.9% | — | — | |
| Q1 2011 | +0.7% | — | — | |
| Q4 2008 | -2.6% | — | — | |
| Q3 2009 | -3.4% | — | — | |
| Q3 2010 | -3.4% | — | — | |
| Q2 2009 | +7.3% | — | — | |
| Q4 2009 | +7.3% | — | — | |
| Q2 2010 | +7.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro